We initially identified the Lin−CD34+CD38−CD45RA−CD90+ CP-CML stem/progenitor subpopulation as having greater proliferative and colony-forming capacity than normal HSCs. This evidence concerns the gene CP and chronic myelogenous leukemia, BCR-ABL1 positive.